Tags

Type your tag names separated by a space and hit enter

Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
Diagn Cytopathol 2017; 45(5):384-390DC

Abstract

BACKGROUND

In 2014, liquid-based cytology with HPV triage replaced conventional cytology. The aim of our study was to compare conventional and liquid-based cytology (LBC), estimate the prevalence of abnormal cervical cytology and high risk HPV (hrHPV) infection and their correlation, among screened women in Luxembourg.

METHODS

Between the first January 2013 and 31st December 2015, 315,868 cervical samples from 150,815 women (mean age 42.2 years) were investigated by the national cytology laboratory. Slides were prepared and screened according to European Guidelines. All cytological results were classified according to the Bethesda 2001 system terminology.

RESULTS

The prevalence of abnormal cervical lesions was as follows: atypical squamous cells of undetermined significance (ASC-US), 1.3%; low-grade squamous intraepithelial lesion (LSIL), 1.9%; high-grade squamous intraepithelial lesion (HSIL), 0.4%. The detection rate of cytological lesions was significantly higher with LBC than with conventional cytology. Based on 11,838 samples with concomitant cytology and HPV testing, hrHPV was detected in 9.5, 45.3, 70.0, and 92.6% of women with negative cytology, ASC-US, LSIL, and HSIL, respectively.

CONCLUSION

More cervical lesions were identified using LBC compared to conventional cytology. HrHPV infection was correlated with the severity of intraepithelial lesions. The current findings provide important information to evaluate the prevention of cervical cancer in Luxembourg and for monitoring the future impact of HPV vaccination. Diagn. Cytopathol. 2017;45:384-390. © 2017 Wiley Periodicals, Inc.

Authors+Show Affiliations

Surveillance and Epidemiology of Infectious Diseases, Laboratoire National de Santé, Dudelange, Luxembourg. Department of Obstetrics and Gynecology, Ghent University Hospital, Ghent, Belgium.Department of Medicine, Laboratoire National de Santé, Dudelange, Luxembourg.Department of Medicine, Laboratoire National de Santé, Dudelange, Luxembourg.Unit of Cancer Epidemiology, Belgian Cancer Centre, Scientific Institute of Public Health, Brussels, Belgium.Department of Obstetrics and Gynecology, Ghent University Hospital, Ghent, Belgium.Department of Medicine, Laboratoire National de Santé, Dudelange, Luxembourg.Department of Medicine, Laboratoire National de Santé, Dudelange, Luxembourg.Surveillance and Epidemiology of Infectious Diseases, Laboratoire National de Santé, Dudelange, Luxembourg.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

28247516

Citation

Latsuzbaia, Ardashel, et al. "Introduction of Liquid-based Cytology and Human Papillomavirus Testing in Cervical Cancer Screening in Luxembourg." Diagnostic Cytopathology, vol. 45, no. 5, 2017, pp. 384-390.
Latsuzbaia A, Hebette G, Fischer M, et al. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg. Diagn Cytopathol. 2017;45(5):384-390.
Latsuzbaia, A., Hebette, G., Fischer, M., Arbyn, M., Weyers, S., Vielh, P., ... Mossong, J. (2017). Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg. Diagnostic Cytopathology, 45(5), pp. 384-390. doi:10.1002/dc.23678.
Latsuzbaia A, et al. Introduction of Liquid-based Cytology and Human Papillomavirus Testing in Cervical Cancer Screening in Luxembourg. Diagn Cytopathol. 2017;45(5):384-390. PubMed PMID: 28247516.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg. AU - Latsuzbaia,Ardashel, AU - Hebette,Gaëtan, AU - Fischer,Marc, AU - Arbyn,Marc, AU - Weyers,Steven, AU - Vielh,Philippe, AU - Schmitt,Fernando, AU - Mossong,Joël, Y1 - 2017/03/01/ PY - 2016/12/22/received PY - 2017/01/23/accepted PY - 2017/3/2/pubmed PY - 2017/5/16/medline PY - 2017/3/2/entrez KW - Aptima HPV assay KW - HPV KW - cervical cancer screening KW - cytology KW - liquid-based cytology SP - 384 EP - 390 JF - Diagnostic cytopathology JO - Diagn. Cytopathol. VL - 45 IS - 5 N2 - BACKGROUND: In 2014, liquid-based cytology with HPV triage replaced conventional cytology. The aim of our study was to compare conventional and liquid-based cytology (LBC), estimate the prevalence of abnormal cervical cytology and high risk HPV (hrHPV) infection and their correlation, among screened women in Luxembourg. METHODS: Between the first January 2013 and 31st December 2015, 315,868 cervical samples from 150,815 women (mean age 42.2 years) were investigated by the national cytology laboratory. Slides were prepared and screened according to European Guidelines. All cytological results were classified according to the Bethesda 2001 system terminology. RESULTS: The prevalence of abnormal cervical lesions was as follows: atypical squamous cells of undetermined significance (ASC-US), 1.3%; low-grade squamous intraepithelial lesion (LSIL), 1.9%; high-grade squamous intraepithelial lesion (HSIL), 0.4%. The detection rate of cytological lesions was significantly higher with LBC than with conventional cytology. Based on 11,838 samples with concomitant cytology and HPV testing, hrHPV was detected in 9.5, 45.3, 70.0, and 92.6% of women with negative cytology, ASC-US, LSIL, and HSIL, respectively. CONCLUSION: More cervical lesions were identified using LBC compared to conventional cytology. HrHPV infection was correlated with the severity of intraepithelial lesions. The current findings provide important information to evaluate the prevention of cervical cancer in Luxembourg and for monitoring the future impact of HPV vaccination. Diagn. Cytopathol. 2017;45:384-390. © 2017 Wiley Periodicals, Inc. SN - 1097-0339 UR - https://www.unboundmedicine.com/medline/citation/28247516/Introduction_of_liquid_based_cytology_and_human_papillomavirus_testing_in_cervical_cancer_screening_in_Luxembourg_ L2 - https://doi.org/10.1002/dc.23678 DB - PRIME DP - Unbound Medicine ER -